Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Raloxifene: Magic bullet for heart and bone?

Nature Medicine volume 4, pages 152–153 (1998)Cite this article

Clinical results show that raloxifene benefits heart and bone in postmenopausal women without increasing the risk of uterine cancer but its long-term effects are unknown.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hammond, G.B. Menopause and hormone replacement therapy: An overview. Obstet. Cynecol. 87, 2–15 (1995)

    Article  Google Scholar 

  2. Sato, M., Rippy, M.K. & Bryant, H.U. Raloxifene, tamoxifen, nafoxidine or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J. 10, 905–912 (1996)

    Article  CAS  Google Scholar 

  3. Ward, R.L. et al. Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women. Bone Miner. 22, 87–94 (1993).

    Article  CAS  Google Scholar 

  4. Black, L.J. et al. Raloxifene (LY1 39481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J. Gin. Invest. 93, 63–69 (1994).

    CAS  Google Scholar 

  5. Delmas, P.D. et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 337, 1641–1647 (1997).

    Article  CAS  Google Scholar 

  6. Scharf, M.B. et al. Effects of estrogen replacement therapy on rates of cyclic alternating patterns and hot-flush events during sleep in postmenopausal women: a pilot study. Clinical Therapeutics 19, 304–311 (1997).

    Article  CAS  Google Scholar 

  7. Bergman, A., Karram, M.M. & Bhatia, N.N. Changes in urethral cytology following estrogen administration. Gynecologic & Obstetric Investigation 29, 211–213 (1990).

    Article  CAS  Google Scholar 

  8. Henderson, V.W. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 48, 27–35 (1997)

    Article  Google Scholar 

  9. Meisel, R.L. et al. Antagonism of sexual behavior in female rats by ventromedial hypothalamic implants of antiestrogen. Neuroendocrinology 45, 201–207 (1987).

    Article  CAS  Google Scholar 

  10. Kuiper, G.G. & Gustafsson, J.-Å. The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and antiestrogens. FEBS Letts. 410, 87–90 (1997).

    Article  CAS  Google Scholar 

  11. Paech, K. et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites). Science 277, 1508–1510 (1997).

    Article  CAS  Google Scholar 

  12. Brzozowski, A.M. et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753–758 (1997)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Nutrition and Department of Biosciences, Karolinska Institute, NOVUM,

    Jan-ÅKe Gustafsson

Authors
  1. Jan-ÅKe Gustafsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gustafsson, JÅ. Raloxifene: Magic bullet for heart and bone?. Nat Med 4, 152–153 (1998). https://doi.org/10.1038/nm0298-152

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0298-152

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing